Cargando…

Pharmaco-proteogenomic profiling of pediatric diffuse midline glioma to inform future treatment strategies

Diffuse midline glioma (DMG) is a deadly pediatric and adolescent central nervous system (CNS) tumor localized along the midline structures of the brain atop the spinal cord. With a median overall survival (OS) of just 9–11-months, DMG is characterized by global hypomethylation of histone H3 at lysi...

Descripción completa

Detalles Bibliográficos
Autores principales:	Findlay, Izac J., De Iuliis, Geoffry N., Duchatel, Ryan J., Jackson, Evangeline R., Vitanza, Nicholas A., Cain, Jason E., Waszak, Sebastian M., Dun, Matthew D.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8782719/ https://www.ncbi.nlm.nih.gov/pubmed/34759345 http://dx.doi.org/10.1038/s41388-021-02102-y

Ejemplares similares

Preclinical and clinical evaluation of German-sourced ONC201 for the treatment of H3K27M-mutant diffuse intrinsic pontine glioma
por: Duchatel, Ryan J, et al.
Publicado: (2021)

ONC201 in Combination with Paxalisib for the Treatment of H3K27-Altered Diffuse Midline Glioma
por: Jackson, Evangeline R., et al.
Publicado: (2023)

The intrinsic and microenvironmental features of diffuse midline glioma: Implications for the development of effective immunotherapeutic treatment strategies
por: Persson, Mika L, et al.
Publicado: (2022)

DIPG-64. INTERNATIONAL PRECLINICAL DRUG DISCOVERY AND BIOMARKER PROGRAM INFORMING AN ADOPTIVE COMBINATORIAL TRIAL FOR DIFFUSE MIDLINE GLIOMAS
por: Przystal*, Justyna M, et al.
Publicado: (2020)

Therapeutic targeting of prenatal pontine ID1 signaling in diffuse midline glioma
por: Messinger, Dana, et al.
Publicado: (2022)

DIPG-32. AKT SIGNALING DRIVES RESISTANCE TO ONC201 IN DIFFUSE INTRINSIC PONTINE GLIOMA (DIPG)
por: Jackson, Evangeline R, et al.
Publicado: (2020)

Pediatric Diffuse Midline Gliomas: An Unfinished Puzzle
por: Di Ruscio, Valentina, et al.
Publicado: (2022)

A Protocol for the Generation of Treatment-naïve Biopsy-derived Diffuse Intrinsic Pontine Glioma and Diffuse Midline Glioma Models
por: Biery, Matt C., et al.
Publicado: (2020)

B-cell Lymphoma 6 (BCL6): From Master Regulator of Humoral Immunity to Oncogenic Driver in Pediatric Cancers
por: McLachlan, Tabitha, et al.
Publicado: (2022)

IMG-10. MRI-BASED RADIOMIC PROGNOSTIC MARKERS OF DIFFUSE MIDLINE GLIOMA
por: Tam, Lydia, et al.
Publicado: (2020)

HGG-24. PRECLINICAL EFFICACY OF THE BRAIN PENETRANT CYCLIN-DEPENDENT KINASE INHIBITOR ZOTIRACICLIB IN PEDIATRIC DIFFUSE MIDLINE GLIOMAS
por: Mueller, Timothy, et al.
Publicado: (2021)

Radio-Resistance and DNA Repair in Pediatric Diffuse Midline Gliomas
por: Pedersen, Henriette, et al.
Publicado: (2020)

Immunotherapy approaches for the treatment of diffuse midline gliomas
por: Bernstock, Joshua D., et al.
Publicado: (2022)

Interdisciplinary care of children with diffuse midline glioma
por: Coleman, Christina, et al.
Publicado: (2022)

The promise of metabolic imaging in diffuse midline glioma
por: Lovibond, Samantha, et al.
Publicado: (2023)

Integrated pharmaco-proteogenomics defines two subgroups in isocitrate dehydrogenase wild-type glioblastoma with prognostic and therapeutic opportunities
por: Oh, Sejin, et al.
Publicado: (2020)

CNSC-01. GABAERGIC NEURON-TO-GLIOMA SYNAPSES IN DIFFUSE MIDLINE GLIOMAS
por: Barron, Tara, et al.
Publicado: (2023)

Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
por: du Chatinier, Aimée, et al.
Publicado: (2022)

Clinical and Genomic Characteristics of Adult Diffuse Midline Glioma
por: Park, Changhee, et al.
Publicado: (2021)

Therapeutic Targets in Diffuse Midline Gliomas—An Emerging Landscape
por: Hayden, Elisha, et al.
Publicado: (2021)

DIPG-44. DIFFUSE MIDLINE GLIOMA WITH EXTRACRANIAL METASTASIS
por: Larsen, Alexandra Giantini, et al.
Publicado: (2023)

Phase I dose escalation and expansion trial of single agent ONC201 in pediatric diffuse midline gliomas following radiotherapy
por: Gardner, Sharon L, et al.
Publicado: (2022)

Epidemiology, Diagnostic Strategies, and Therapeutic Advances in Diffuse Midline Glioma
por: Miguel Llordes, Gloria, et al.
Publicado: (2023)

Standardization of the liquid biopsy for pediatric diffuse midline glioma using ddPCR
por: Li, Daphne, et al.
Publicado: (2021)

DIPG-09. Diffuse Midline Glioma-Adaptive Combinatory Trial (DMG-ACT): A biology-driven platform trial in pediatric and young adult patients with diffuse midline glioma
por: Franson, Andrea, et al.
Publicado: (2022)

Harmonization of postmortem donations for pediatric brain tumors and molecular characterization of diffuse midline gliomas
por: Kambhampati, Madhuri, et al.
Publicado: (2020)

Diffuse midline glioma in the spinal cord with rapid respiratory deterioration
por: Kamidani, Ryo, et al.
Publicado: (2020)

DIPG-39. New preclinical models for Diffuse Midline Glioma
por: Klenner, Marbod, et al.
Publicado: (2022)

DIPG-06. Uncovering the FACTs in Diffuse Midline Glioma (DMG)
por: Holliday, Holly, et al.
Publicado: (2022)

A homogeneous treatment for non-DIPG diffuse midline glioma
por: Schiavello, Elisabetta, et al.
Publicado: (2022)

Diffuse midline glioma treated with epigenetic agent-based immunotherapy
por: Jing, Linkai, et al.
Publicado: (2023)

Defining tumor-associated vascular heterogeneity in pediatric high-grade and diffuse midline gliomas
por: Wei, Xin, et al.
Publicado: (2021)

Pediatric diffuse midline glioma: Understanding the mechanisms and assessing the next generation of personalized therapeutics
por: Jovanovich, Nicolina, et al.
Publicado: (2023)

Corrigendum to: Generation of immunocompetent syngeneic allograft mouse models for pediatric diffuse midline glioma
Publicado: (2023)

CLRM-05 FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS
por: Dalmage, Mahalia, et al.
Publicado: (2022)

A tumor suppressor role for EZH2 in diffuse midline glioma pathogenesis
por: Dhar, Swati, et al.
Publicado: (2022)

TRLS-02. FEASIBILITY OF EVALUATING ABEMACICLIB NEUROPHARMACOKINETICS OF DIFFUSE MIDLINE GLIOMA USING INTRATUMORAL MICRODIALYSIS
por: Jackson, Sadhana, et al.
Publicado: (2023)

Therapeutic HDAC inhibition in hypermutant diffuse intrinsic pontine glioma
por: Noll, Alyssa, et al.
Publicado: (2023)

Current knowledge on the immune microenvironment and emerging immunotherapies in diffuse midline glioma
por: Price, Gabrielle, et al.
Publicado: (2021)

Flank Pain as a First Symptom of a Diffuse Midline Glioma
por: Bassa, Burc, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_b8fvlrbuau63a631qstseb9ogt